Malaria sporozoites must first undergo intrahepatic development before a pathogenic blood-stage infection is established. The success of infection depends on host and parasite factors. In healthy human volunteers undergoing controlled human malaria infection (CHMI), we directly compared three clinical Plasmodium falciparum isolates for their ability to infect primary human hepatocytes in vitro and to drive the production of blood-stage parasites in vivo. Our data show a correlation between the efficiency of strain-specific sporozoite invasion of human hepatocytes and the dynamics of patent parasitemia in study subjects, highlighting intrinsic differences in infectivity among P. falciparum isolates from distinct geographical locales. The observed heterogeneity in infectivity among strains underscores the value of assessing the protective efficacy of candidate malaria vaccines against heterologous strains in the CHMI model.

Additional Metadata
Persistent URL dx.doi.org/10.1126/scitranslmed.aag2490, hdl.handle.net/1765/100692
Journal Science Translational Medicine
Note No subscription
Citation
McCall, M.A, Wammes, L.J, Langenberg, M.C.C. (Marijke C.C.), Van Gemert, G.-J. (Geert-Jan), Walk, J. (Jona), Hermsen, C.C, … Sauerwein, R.W. (2017). Infectivity of Plasmodium falciparum sporozoites determines emerging parasitemia in infected volunteers. Science Translational Medicine, 9(395). doi:10.1126/scitranslmed.aag2490